News

US to invest $1.6bn into rare earths group in bid to shore up key minerals

Unlock the White House Watch newsletter for freeYour guide to what Trump’s second term means for Washington, business and the

News

Editor's Top Picks

Mark Rutte, Europe’s Trump whisperer-in-chief

The morning after striking a deal with Donald Trump over Greenland that appeared to have eased the biggest crisis in

News

Your one-stop resource for personal news and tips.

Join our newsletter to get the latest news directly to your inbox.

More form News

Should You T-Bill And Chill?

T-Bills are an incredibly attractive option at this time. At 5.5%, you’re getting high income,

Winners don’t do irony

Receive free Life & Arts updatesWe’ll send you a myFT Daily Digest email rounding up

Cidara Therapeutics: Reduced Risk Due to Janssen’s Decision And Progress In The Pipeline

Overview of the thesis In my prior coverage of Cidara Therapeutics (NASDAQ:CDTX) I gave a

What is it about men and the Roman empire?

Receive free Life & Arts updatesWe’ll send you a myFT Daily Digest email rounding up

U.S. Fund Investors Tap The Brakes In August

This article was written byTom Roseen is the Head of Research Services, joining from Janus

Giorgio Napolitano, former president of Italy, dies aged 98

Receive free Italian politics updatesWe’ll send you a myFT Daily Digest email rounding up the

My Favorite Railroad – Why Billionaires Own Canadian Pacific Kansas City (NYSE:CP)

All financial numbers in this article are in Canadian dollars unless noted otherwise. Introduction It's

When it’s time to dial down the volume

Receive free Life & Arts updatesWe’ll send you a myFT Daily Digest email rounding up

McDonald’s: A Bit Pricey But Very Interesting (NYSE:MCD)

When it comes to dividend-paying companies with a very long history of growth, few compare

The west’s Modi problem

On September 10, Narendra Modi led Joe Biden, Rishi Sunak, Justin Trudeau and other world

Protagonist Therapeutics: There Are Reasons Behind Johnson & Johnson’s Optimism (PTGX)

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) is developing JNJ-2113 (PN-235), an oral IL-23 drug targeting psoriasis, however

Lachlan Murdoch: now the leading man in a long-running family drama

In 2005, a frustrated 33-year-old Lachlan Murdoch met his father for lunch in Los Angeles

Texas Pacific Land’s Management Issues Coming To An End (NYSE:TPL)

Investment Thesis Texas Pacific Land Corporation (NYSE:TPL) has one of those outstanding business models that

Investors devour risky corporate debt in boost to LBO business

Receive free Leveraged loans updatesWe’ll send you a myFT Daily Digest email rounding up the

Coinbase: Bullish Seasonality, But Is That Enough? (NASDAQ:COIN)

Risk assets have been bid down aggressively in the past couple of months, as typically